ReviewFrontiers in neuroergonomics2026
EEG hyperscanning in intellectual disability: a scoping review with implications for cognitive stimulation therapy.
Review in Frontiers in neuroergonomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electroencephalography (EEG) hyperscanning has emerged as a valuable method for examining social dynamics during group-based activities and may serve as a promising outcome measure in group interventions. Cognitive stimulation therapy (CST) is one such interventions shown to improve cognition and quality of life in people with dementia and has recently been adapted for individuals with intellectual disability (ID). However, the potential for obtaining objective neural markers of CST benefit via EEG and hyperscanning is yet to be explored. This scoping review aims to identify existing evidence and gaps related to the use of EEG within CST research for adults with ID by examining three relevant areas: (1) the use of individual EEG and hyperscanning to evaluate cognitive and social outcomes in CST; (2) the evidence base for individual and group-based CST in people with ID; and (3) the use of EEG to evaluate cognitive and social outcomes for people with ID. Following the PRISMA-ScR guidelines, studies were searched in CINAHL, MEDLINE, PsychInfo, and EMBASE. Our search focused on adult participants with ID and studies that used EEG for the purpose of evaluating cognitive or social outcomes. Currently, there are no studies that use EEG to evaluate CST in adults with ID. Following screening and eligibility assessment, no studies met the inclusion criteria for EEG and CST. Five studies were included for CST and ID, and 14 articles met criteria for EEG and ID. In total, 19 articles were included in the final review. The evidence base suggests that EEG has been successfully used to investigate neural mechanism in ID and Down Syndrome related Alzheimer's disease. Existing CST research in ID remains largely feasibility-focused but some preliminary findings show cognitive benefits, enhanced enjoyment, and social connectedness. Our review shows that there is a large gap when it comes to any objective metrics for CST in general. Given that there is evidence of EEG studies including populations with ID, we propose that this gap can be filled by EEG hyperscanning which offers a non-invasive, objective approach to evaluate cognitive and social outcomes in people with ID in future CST research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.